Schedule 13G ownership disclosure
TONIX PHARMACEUTICALS HLDG C
Common Stock, par value $0.001 per share · CUSIP: 890260847
Event date: 2024-12-31
- Filing-level shares
- 0.00
- Percent of class
- 0%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000278
- Form type
- SCHEDULE 13G/A
- Filer
- L1 Capital Global Opportunities Master Fund, Ltd.
- CIK
- CIK 1702202
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership